Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × Mesalamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Recurrence 1 Psoriasis 1 Neoplasms 1 Lymphoma, Follicular 1 Inflammatory Bowel Diseases 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Adenoma 1

Interventions

etrolizumab 4 Infliximab 4 Nivolumab 3 Specimen Handling 2 Educational Status 2 Colonoscopy 2 vedolizumab 1 pembrolizumab 1 peficitinib 1 golimumab 1 Vitamin E 1 Sutures 1 Surgical Instruments 1 Standard of Care 1 Ringer's Lactate 1 Proctocolectomy, Restorative 1 Proctectomy 1 Practice Guidelines as Topic 1 Pneumococcal Vaccines 1 Papillomavirus Vaccines 1 Narrow Band Imaging 1 NX-13 1 Methylprednisolone 1 Methods 1 Mesalamine 1 Medical Marijuana 1 Lysine Acetyltransferase 5 1 Loperamide 1 Iron-Dextran Complex 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093663 2021-06-09

PACE

Takeda

Phase 3 Completed

107 enrolled 18 charts

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡